Immediate Management of Diabetic Ketoacidosis
Initial Resuscitation and Assessment
Begin aggressive isotonic saline (0.9% NaCl) at 15–20 mL/kg/hour (approximately 1–1.5 L in the first hour) immediately upon recognition of DKA to restore intravascular volume and renal perfusion. 1, 2
Simultaneously obtain:
- Plasma glucose, venous pH, serum electrolytes with calculated anion gap, β-hydroxybutyrate (preferred over urine ketones), BUN, creatinine, effective serum osmolality 1, 2
- Urinalysis, complete blood count, ECG 1, 2
- Blood, urine, and throat cultures if infection is suspected (the most common precipitating factor) 1, 2
Calculate corrected serum sodium by adding 1.6 mEq/L for each 100 mg/dL glucose above 100 mg/dL. 1, 2
Critical Potassium Management Before Insulin
DO NOT START INSULIN if serum potassium is < 3.3 mEq/L—this is an absolute contraindication with Class A evidence. 1, 2
Potassium-Based Algorithm:
If K⁺ < 3.3 mEq/L:
- Hold all insulin 1, 2
- Continue isotonic saline at 15–20 mL/kg/hour 1
- Aggressively replace potassium at 20–40 mEq/hour until K⁺ ≥ 3.3 mEq/L 1, 2
- Obtain ECG to assess for cardiac effects of hypokalemia 1
- Confirm adequate urine output (≥ 0.5 mL/kg/hour) before potassium repletion 1, 2
If K⁺ = 3.3–5.5 mEq/L:
- Insulin may be started safely 1, 2
- Add 20–30 mEq/L potassium to each liter of IV fluid (2/3 potassium chloride or acetate + 1/3 potassium phosphate) once urine output is adequate 1, 2
If K⁺ > 5.5 mEq/L:
- Start insulin immediately without delay 1, 2
- Withhold potassium supplementation initially 1, 2
- Monitor potassium every 2–4 hours as levels will fall rapidly with insulin 1, 2
- Begin supplementation once K⁺ falls below 5.5 mEq/L 1, 2
Target serum potassium throughout treatment: 4.0–5.0 mEq/L. 1, 2
Insulin Therapy Protocol
Once serum potassium is confirmed ≥ 3.3 mEq/L, administer an IV bolus of 0.1 units/kg regular insulin followed immediately by continuous infusion at 0.1 units/kg/hour. 1, 2
Insulin Infusion Preparation:
- Mix 100 units regular human insulin in 100 mL of 0.9% sodium chloride (1 unit/mL concentration) 1
- Prime the infusion tubing with 20 mL of the prepared solution before patient connection to prevent insulin adsorption 1
Glucose Decline Targets:
- Aim for glucose decline of 50–75 mg/dL per hour 1, 2
- If glucose does not fall by ≥ 50 mg/dL in the first hour despite adequate hydration, double the insulin infusion rate every hour until steady decline is achieved 1, 2
Critical Insulin Management Rule:
Never stop or reduce insulin when glucose falls to 250 mg/dL—instead, add dextrose to IV fluids while maintaining the same insulin infusion rate. 1, 2 Premature insulin discontinuation is the most common cause of recurrent DKA. 1, 2
Fluid Management After the First Hour
After the initial 1–1.5 L isotonic saline bolus, adjust fluid based on corrected serum sodium: 1, 2
If corrected sodium is normal or elevated:
If corrected sodium is low:
When plasma glucose falls to approximately 250 mg/dL:
- Change IV fluid to 5% dextrose with 0.45–0.75% NaCl 1, 2
- Continue insulin infusion at the same rate to clear ketones and prevent recurrent ketoacidosis 1, 2
Limit the change in serum osmolality to ≤ 3 mOsm/kg/hour to reduce cerebral edema risk. 1, 2
Monitoring Protocol
Check every 2–4 hours until metabolically stable: 1, 2
- Serum electrolytes (especially potassium)
- Blood glucose
- Venous pH (adequate for monitoring; repeat arterial gases generally unnecessary) 1, 2
- Serum bicarbonate and anion gap
- BUN, creatinine, calculated osmolality
Use serum β-hydroxybutyrate for monitoring ketosis resolution—nitroprusside-based urine ketone tests miss the predominant ketone body and should not be used. 1, 2
DKA Resolution Criteria
DKA is resolved when ALL of the following are met: 1, 2
- Glucose < 200 mg/dL
- Serum bicarbonate ≥ 18 mEq/L
- Venous pH > 7.3
- Anion gap ≤ 12 mEq/L
Continue insulin infusion until all criteria are met, regardless of glucose normalization. 1, 2
Transition to Subcutaneous Insulin
Administer long-acting basal insulin (glargine or detemir) subcutaneously 2–4 hours BEFORE stopping the IV insulin infusion. 1, 2 This overlap is essential to prevent rebound hyperglycemia and recurrent DKA—failure to overlap is the most common cause of DKA recurrence. 1
Continue IV insulin for an additional 1–2 hours after the subcutaneous basal dose to ensure adequate absorption. 1, 2
Calculate basal insulin dose as approximately 50% of the total 24-hour IV insulin amount, with the remaining 50% divided among three meals as rapid-acting insulin. 1
Bicarbonate Administration
DO NOT administer bicarbonate for DKA patients with pH > 6.9–7.0. 1, 2, 3 Multiple studies show no benefit in resolution time or outcomes, and bicarbonate may worsen ketosis, cause hypokalemia, and increase cerebral edema risk. 1, 2
For pH < 6.9, consider 100 mmol sodium bicarbonate diluted in 400 mL sterile water, infused at 200 mL/hour. 1, 3
Alternative Approach for Mild-Moderate Uncomplicated DKA
For hemodynamically stable, alert patients with mild-moderate DKA, subcutaneous rapid-acting insulin analogs (0.15 units/kg every 2–3 hours) combined with aggressive fluid management are equally effective, safer, and more cost-effective than IV insulin. 1, 2, 4
This approach requires adequate fluid replacement, frequent point-of-care glucose monitoring, and appropriate follow-up. 1, 2
Common Pitfalls to Avoid
- Starting insulin before correcting hypokalemia (K⁺ < 3.3 mEq/L) can cause fatal cardiac arrhythmias 1, 2
- Stopping insulin when glucose reaches 250 mg/dL without adding dextrose leads to recurrent ketoacidosis 1, 2
- Discontinuing IV insulin without 2–4 hour overlap with subcutaneous basal insulin causes DKA recurrence 1, 2
- Inadequate potassium monitoring and replacement is a leading cause of mortality in DKA 1, 2
- Overly rapid correction of osmolality (> 3 mOsm/kg/hour) increases cerebral edema risk 1, 2
- Relying on urine ketones instead of serum β-hydroxybutyrate delays appropriate therapy 1, 2
Treatment of Precipitating Causes
Identify and treat concurrently: 1, 2
- Infection (most common—obtain cultures and start antibiotics promptly)
- Myocardial infarction
- Cerebrovascular accident
- Insulin omission or inadequacy
- SGLT2 inhibitor use (discontinue immediately and do not restart until 3–4 days after metabolic stability) 1, 2
- Pancreatitis, trauma, or glucocorticoid therapy